Royalty Pharma
NASDAQ: RPRXNew York, US · Founded 1996 · 114 employees on LinkedIn · 2 known investors
Find your way into Royalty Pharma
Royalty Pharma acquires and manages pharmaceutical royalties from approved drugs and therapies, providing investors exposure to the biopharma sector without early-stage development risk. The company operates as a market leader in the pharmaceutical royalty market with a diversified portfolio of long-duration revenue streams.
Founders & leadership
PL
Pablo LegorretainFounder & Chief Executive Officer
Investors · 2
In the news
A heart-disease treatment trial missed its main goal. Royalty Pharma expects to recoup its investment.stocktitan.net · Sep 2026Frequently asked questions
- What does Royalty Pharma do?
- Royalty Pharma acquires and manages pharmaceutical royalties from approved drugs and therapies, providing investors exposure to the biopharma sector without early-stage development risk. The company operates as a market leader in the pharmaceutical royalty market with a diversified portfolio of long-duration revenue streams.
- Who are Royalty Pharma's investors?
- Royalty Pharma's investors include Paladin Capital Group, Scientia Ventures.
- Where is Royalty Pharma headquartered?
- Royalty Pharma is headquartered in New York, US.